51 related articles for article (PubMed ID: 29574528)
1. Serum MicroRNA-146b Expression for Malignancy Prediction in Euthyroid Patients with Indeterminate Thyroid Nodules.
Abdelfadeil AO; Halawa MR; Zaky I; Samy M; Salem L; Bahaaeldin AM
Egypt J Immunol; 2024 Jan; 31(1):40-47. PubMed ID: 38224034
[TBL] [Abstract][Full Text] [Related]
2. Cyto-Histological Profile of MicroRNAs as Diagnostic Biomarkers in Differentiated Thyroid Carcinomas.
Matos ML; Pinto M; Alves M; Canberk S; Gonçalves A; Bugalho MJ; Papoila AL; Soares P
Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540448
[TBL] [Abstract][Full Text] [Related]
3. Effective Use of microRNA, BRAF and Sonographic Risk Assessment in Bethesda III Thyroid Nodules Requires a Different Approach to Nodules with Features of Nuclear Atypia and Other Types of Atypia.
Słowińska-Klencka D; Popowicz B; Kulczycka-Wojdala D; Szymańska B; Duda-Szymańska J; Wojtaszek-Nowicka M; Kaczka K; Klencki M
Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686562
[TBL] [Abstract][Full Text] [Related]
4. Differential microRNA expression for diagnosis and prognosis of papillary thyroid cancer.
Ruiz-Pozo VA; Cadena-Ullauri S; Guevara-Ramírez P; Paz-Cruz E; Tamayo-Trujillo R; Zambrano AK
Front Med (Lausanne); 2023; 10():1139362. PubMed ID: 37089590
[TBL] [Abstract][Full Text] [Related]
5. The Importance of miRNA in the Diagnosis and Prognosis of Papillary Thyroid Cancer.
Rogucki M; Buczyńska A; Krętowski AJ; Popławska-Kita A
J Clin Med; 2021 Oct; 10(20):. PubMed ID: 34682861
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy-associated plasma protein A mRNA expression as a marker for differentiated thyroid cancer: results from a "surgical" and a "cytological" series.
Marzocchi C; Capezzone M; Sagnella A; Cartocci A; Caroli Costantini M; Brindisi L; Mancini V; Cantara S; Castagna MG
J Endocrinol Invest; 2022 Feb; 45(2):369-378. PubMed ID: 34350538
[TBL] [Abstract][Full Text] [Related]
7. The changes in miR-221 and miR-222 before and after interventional therapy of coronary heart disease and analysis of their correlation with inflammatory factors and prognosis.
Wang Y; Deng H; Xu Z; Xu P; Huo T; Xu Z; Guo M
Am J Transl Res; 2021; 13(4):3731-3737. PubMed ID: 34017558
[TBL] [Abstract][Full Text] [Related]
8. Evaluating pre- and post-operation plasma miRNAs of papillary thyroid carcinoma (PTC) patients in comparison to benign nodules.
Rezaei M; Khamaneh AM; Zarghami N; Vosoughi A; Hashemzadeh S
BMC Cancer; 2019 Jul; 19(1):690. PubMed ID: 31307429
[TBL] [Abstract][Full Text] [Related]
9. Thyroid nodules with Hürthle cells: the malignancy risk in relation to the FNA outcome category.
Słowińska-Klencka D; Wysocka-Konieczna K; Woźniak-Oseła E; Sporny S; Popowicz B; Sopiński J; Kaczka K; Kuzdak K; Pomorski L; Klencki M
J Endocrinol Invest; 2019 Nov; 42(11):1319-1327. PubMed ID: 31077094
[TBL] [Abstract][Full Text] [Related]
10. Molecular Signature of Indeterminate Thyroid Lesions: Current Methods to Improve Fine Needle Aspiration Cytology (FNAC) Diagnosis.
Cantara S; Marzocchi C; Pilli T; Cardinale S; Forleo R; Castagna MG; Pacini F
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28383480
[TBL] [Abstract][Full Text] [Related]
11. Role of Ancillary Techniques in Thyroid Cytology Specimens.
Nishino M; Krane JF
Acta Cytol; 2020; 64(1-2):40-51. PubMed ID: 30947167
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA expression profile of thyroid nodules in fine-needle aspiration cytology: a confirmatory series.
Castagna MG; Marzocchi C; Pilli T; Forleo R; Pacini F; Cantara S
J Endocrinol Invest; 2019 Jan; 42(1):97-100. PubMed ID: 29574528
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA expression profile helps to distinguish benign nodules from papillary thyroid carcinomas starting from cells of fine-needle aspiration.
Agretti P; Ferrarini E; Rago T; Candelieri A; De Marco G; Dimida A; Niccolai F; Molinaro A; Di Coscio G; Pinchera A; Vitti P; Tonacchera M
Eur J Endocrinol; 2012 Sep; 167(3):393-400. PubMed ID: 22728346
[TBL] [Abstract][Full Text] [Related]
14. Implications of a suspicious afirma test result in thyroid fine-needle aspiration cytology: an institutional experience.
Lastra RR; Pramick MR; Crammer CJ; LiVolsi VA; Baloch ZW
Cancer Cytopathol; 2014 Oct; 122(10):737-44. PubMed ID: 25123499
[TBL] [Abstract][Full Text] [Related]
15. Digital gene expression profiling of a series of cytologically indeterminate thyroid nodules.
Giannini R; Torregrossa L; Gottardi S; Fregoli L; Borrelli N; Savino M; Macerola E; Vitti P; Miccoli P; Basolo F
Cancer Cytopathol; 2015 Aug; 123(8):461-70. PubMed ID: 26033834
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
